AI assistant
Sending…
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014
Dec 17, 2014
31580_dirs_2014-12-17_8f32a60c-263f-44e8-a08f-7a9eb375cf60.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-12-15
Reporting Person: Cantley Lewis Clayton Jr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-15 | Common stock | G | 181818 | $0.00 | Disposed | 181818 | Direct |
| 2014-12-15 | Common stock | G | 181818 | $0.00 | Acquired | 181818 | Indirect |
Footnotes
F1: Reflects a gift of shares from the reporting person to his spouse, who shares the same household as the reporting person.
F2: Shares held by Vicki Lee Sato, who is the reporting person's spouse.
More from AGIOS PHARMACEUTICALS, INC.
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3